i've been on semaglutide for Your Weight Loss Journey: What You Need to Know Medical Weight Loss Program |

This study suggests allulose stimulates GLP-1 production (like semaglutide, mounjaro, etc) which suppresses appetite

Adding AOD 9604 targeted fat breakdown may shift this ratio even further toward preferential fat loss, though controlled studies of the combination are limited

Following 12-weeks of treatment with the GLP-1 receptor agonist exenatide, cognitive testing was repeated in participants

AHA Journals

What to expect during the switch: 7-day gap: Stop Mounjaro on your normal injection day, then wait 7 days before starting Wegovy Starting fresh: Begin with the lowest Wegovy dose (0.25mg) regardless of your previous Mounjaro dose Gradual increase: Your dose will be increased every 4 weeks as tolerated Side effects may return: Mild nausea, stomach upset, or changes in appetite are normal initially Timeline: Week 1: Final Mounjaro dose Week 2: No medication (washout period) Week 3: Start Wegovy 0.25mg Weeks 3-6: Continue 0.25mg weekly Weeks 7-10: Increase to 0.5mg if tolerated Continue: Following the standard Wegovy dose schedule Wegovy Dose Escalation Schedule Following the 7-day washout period, you'll start Wegovy at the lowest dose and gradually increase according to the established titration schedule: Weeks 1-4 (of Wegovy treatment): 0.25 mg weekly Weeks 5-8: 0.5 mg weekly Weeks 9-12: 1.0 mg weekly Weeks 13-16: 1.7 mg weekly Week 17 onwards: 2.4 mg weekly (maintenance dose) This methodical approach allows your body to adapt progressively, minimising potential side effects and maximising treatment tolerability

Unlike multi-receptor agonists, Semaglutide provides researchers with a highly selective model for investigating GLP-1 receptor-mediated biological responses